dc.description.abstract | Herbal-flavonoids (HF) as polyphenolic secondary metabolites are taken
in the daily diet to join in many metabolic processes in the human
organism. Anti-proliferative activities and human serum albumin (HSA)
binding capacities of herbal-flavonoids namely 7,5'-dimethoxyisoetin
(HF1), homoorientin-6 `'-4-O-methyl-myo-inositol (HF2), (2R,
3R)-(+)-dihydrokaempferol-7,4'-dimethylether (HF3),
eriodictyol-7,4'-dimethylether (HF4) and flavonoids isoorientin (HF5)
and genkwanin (HF6) were investigated. Anti-proliferative activities
were determined by the xCELLigence system by treatment with human
prostate (PC3) and cervical cancer (HeLa) cells. The binding capacities
were studied by two-dimensional (2D-FL) and three-dimensional (3D-FL)
fluorescence spectroscopy. HeLa and PC3 cell lines were treated with
flavonoids at 10, 50 and 100 mu g/mL concentrations over a 48 hour
period. Stable anti-proliferative efficacy plots were obtained for
tested flavonoids. From the flavonoids, HF3 and HF4 showed the strongest
anti-proliferative effect against PC3 and HeLa cell line. HF1 and HF2
exhibited the strongest binding capacity to the HSA corresponding to K-b
values of 3.81 x 10(4) M-1 and 6.00 x 10(4) M-1, respectively. The
studies revealed that the flavonoids form the basis of in vivo
preclinical studies as important nutraceuticals of the daily diet, as
well as modelled in medical and pharmacological applications. | |